CUE
Cue Biopharma, Inc.
Key Financials
Revenue
$27.5M
↑ 195.7%
Net Income
$-26602000
↑ 34.6%
Operating Income
$-26552000
↑ 36.0%
Total Assets
$42.2M
↑ 31.1%
EPS (Diluted)
$-0.28
↑ 61.1%
Total Liabilities
$15.8M
↑ 7.4%
Cash & Equivalents
$27.1M
↑ 20.8%
Shareholders' Equity
$26.4M
↑ 51.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CUE |
| Company Name | Cue Biopharma, Inc. |
| CIK | 1645460 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-949-2680 |